TECHNOLOGY & DEVICES

OVERVIEW2022-06-07T23:30:46+00:00

OVERVIEW

Electroporation (EP) utilizes the application of electrical fields in a target tissue to significantly increase intracellular nucleic acid uptake in the local area, resulting in enhanced gene expression compared to conventional methods of administration.

Muscle or skin cells in vivo

Nucleic Acid Administration

Electroporation Application

Intracellular DNA Uptake

Cell Recovery

Gene Expression

BENEFITS OF THE TRIGRID DELIVERY SYSTEM

  •  Enhanced delivery of nucleic acid drug candidates
  •  Ease of use for clinical delivery of nucleic acid drugs
  •  Integrated and automated patented design
  •  Devices adapted for every stage of development from early non-clinical through commercial deployment

APPLICATIONS

Ichor’s TriGrid technology provides a delivery solution for nucleic acid candidates in two broad categories:

Nucleic Acid Vaccines / Immunotherapeutics
  • Alternative to traditional vaccine approaches
    • Prevention of Infectious Diseases
  • Immunotherapy / novel vaccine indications
    • Oncology
    • Chronic viral infection
    • Autoimmune disease, allergy
Protein / Monoclonal antibody (mAb) delivery
  • Alternative to systemic delivery of recombinants
    • Approved and/or novel agents
    • Low cost, sustained passive immunity (mAb)
  • Locoregional protein expression
    • Growth factors for revascularization / wound healing
    • Immunomodulators